Experienced Leader in Scientific and Medical companies to Lead Operations.
Williamsburg, Virginia, March 2, 2016 (Newswire.com) - ivWatch is pleased to welcome Mike Gahan as Vice President of Operations. He officially joined the ivWatch team on February 15, 2016.
Previous to ivWatch, Mr. Gahan served as Vice President of Operations at Transnetyx. Mr. Gahan was responsible for the day-to-day operations of the company, including the management of Medical Laboratory Technicians and Medical Technologists and their supervisors as well as engineering, maintenance and logistics to maintain daily operations, planning for expansions, inventory management, and overall assurance that capacity meets client demand. Transnetyx is a molecular diagnostics company providing high throughput, automated genetic testing services to the research industry. Mr. Gahan also served as Vice President of Operations of Harmonyx, Inc., a sister company of Transnetyx, which is a CLIA/CAP certified and HIPAA compliant automated pharmacogenetic testing laboratory.
Prior to joining Transnetyx in 2004 (initially as Operations Manager until he became Vice President of Operations in 2008) and Harmonyx in 2008, Mr. Gahan was with Ciba Specialty Chemicals for 17 years in a variety of roles, including development engineer, automation engineer, production engineer, programs manager, project leader and operations manager. While with Ciba, he was responsible for two production units with a $60 million asset value, producing $50 million in annual sales of specialty monomers.
In his role of Vice President of Operations at ivWatch, Mr. Gahan will be responsible for leading the company’s day to day operation enabling increased organizational alignment to achieve greater efficiencies as ivWatch continues to grow.
About ivWatch, LLC
ivWatch, LLC is a medical device manufacturer focused on improving the safety and effectiveness of intravenous (IV) therapy. The company’s technology aids clinicians by continuously monitoring a patient's peripheral IV, providing early detection of IV infiltrations. To learn more, visit www.ivWatch.com.
855-489-2824 ext. 7031